These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 23404503)

  • 1. UHRF2, a ubiquitin E3 ligase, acts as a small ubiquitin-like modifier E3 ligase for zinc finger protein 131.
    Oh Y; Chung KC
    J Biol Chem; 2013 Mar; 288(13):9102-11. PubMed ID: 23404503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small ubiquitin-like modifier (SUMO) modification of zinc finger protein 131 potentiates its negative effect on estrogen signaling.
    Oh Y; Chung KC
    J Biol Chem; 2012 May; 287(21):17517-17529. PubMed ID: 22467880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity.
    Yang WS; Campbell M; Kung HJ; Chang PC
    J Vis Exp; 2018 Jan; (131):. PubMed ID: 29443041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic.
    Goffinont S; Coste F; Prieu-Serandon P; Mance L; Gaudon V; Garnier N; Castaing B; Suskiewicz MJ
    J Biol Chem; 2023 Jul; 299(7):104870. PubMed ID: 37247759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical characterization of SUMO-conjugating enzymes by in vitro sumoylation assays.
    Eisenhardt N; Ilic D; Nagamalleswari E; Pichler A
    Methods Enzymol; 2019; 618():167-185. PubMed ID: 30850051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of phosphorylation sites of TOPORS and a role for serine 98 in the regulation of ubiquitin but not SUMO E3 ligase activity.
    Park HJ; Zheng H; Kulkarni D; Kerrigan J; Pungaliya P; Saleem A; Rubin EH
    Biochemistry; 2008 Dec; 47(52):13887-96. PubMed ID: 19053840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral control of the SUMO pathway: Gam1, a model system.
    Chiocca S
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1419-21. PubMed ID: 18031235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo.
    Weger S; Hammer E; Heilbronn R
    FEBS Lett; 2005 Sep; 579(22):5007-12. PubMed ID: 16122737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necdin promotes ubiquitin-dependent degradation of PIAS1 SUMO E3 ligase.
    Gur I; Fujiwara K; Hasegawa K; Yoshikawa K
    PLoS One; 2014; 9(6):e99503. PubMed ID: 24911587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMO E3 ligase activity of TRIM proteins.
    Chu Y; Yang X
    Oncogene; 2011 Mar; 30(9):1108-16. PubMed ID: 20972456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yeast PIAS-type Ull1/Siz1 is composed of SUMO ligase and regulatory domains.
    Takahashi Y; Kikuchi Y
    J Biol Chem; 2005 Oct; 280(43):35822-8. PubMed ID: 16109721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UHRF2, another E3 ubiquitin ligase for p53.
    Bai L; Wang X; Jin F; Yang Y; Qian G; Duan C
    Biochem Biophys Res Commun; 2012 Sep; 425(4):908-11. PubMed ID: 22902639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sumoylation as a signal for polyubiquitylation and proteasomal degradation.
    Miteva M; Keusekotten K; Hofmann K; Praefcke GJ; Dohmen RJ
    Subcell Biochem; 2010; 54():195-214. PubMed ID: 21222284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53.
    Rajendra R; Malegaonkar D; Pungaliya P; Marshall H; Rasheed Z; Brownell J; Liu LF; Lutzker S; Saleem A; Rubin EH
    J Biol Chem; 2004 Aug; 279(35):36440-4. PubMed ID: 15247280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms in SUMO conjugation.
    Varejão N; Lascorz J; Li Y; Reverter D
    Biochem Soc Trans; 2020 Feb; 48(1):123-135. PubMed ID: 31872228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
    Zhang J; Goodson ML; Hong Y; Sarge KD
    J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
    Reverter D; Lima CD
    Nature; 2005 Jun; 435(7042):687-92. PubMed ID: 15931224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E3 ubiquitin-protein ligase TRIM21-mediated lysine capture by UBE2E1 reveals substrate-targeting mode of a ubiquitin-conjugating E2.
    Anandapadamanaban M; Kyriakidis NC; Csizmók V; Wallenhammar A; Espinosa AC; Ahlner A; Round AR; Trewhella J; Moche M; Wahren-Herlenius M; Sunnerhagen M
    J Biol Chem; 2019 Jul; 294(30):11404-11419. PubMed ID: 31160341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity.
    Pao KC; Wood NT; Knebel A; Rafie K; Stanley M; Mabbitt PD; Sundaramoorthy R; Hofmann K; van Aalten DMF; Virdee S
    Nature; 2018 Apr; 556(7701):381-385. PubMed ID: 29643511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.